As prostate-specific membrane antigen (PSMA) is overexpressed in most prostate cancers, radiolabeled PSMA shows higher diagnostic sensitivity in detecting lymph node and distant metastasis, recurrences, and intraoperative tumor localization than other imaging modalities [11]. Here, FOLH1 is linked to prostate cancer.